Business Daily Media

Men's Weekly

.

Hong Kong Baptist University scientists develop versatile compound for treating Alzheimer’s disease

HONG KONG SAR - Media OutReach - 24 August 2022 - A study led by researchers from Hong Kong Baptist University (HKBU) has demonstrated that a multifunctional organic compound named F-SLOH has the potential to treat Alzheimer's disease (AD) at an early stage.

The team found that it can inhibit the aggregation of amyloid-beta (Aβ), and reduce the hyperphosphorylation of tau proteins and neuroinflammation in the brain to improve the pathological features of AD. The findings have been published in the international academic journal Redox Biology.

Caption
The study conducted by Professor Li Min (left), Professor Ricky Wong Man-shing (right) and Dr Iyaswamy Ashok (middle) provides the first in vivo evidence that F-SLOH is an effective agent that can target and treat multiple neurodegenerative changes in an AD mouse model.

AD is the most common cause of dementia. It accounts for nearly 65% of dementia cases in elderly Hong Kong Chinese. It is pathologically characterised by the abnormal aggregation of Aβ, the hyperphosphorylation of tau proteins and neuroinflammation in the nerve cells in the brain, which cause progressive neuronal loss and cognitive impairment. Currently there is no cure for AD, and the available medicines can only relieve its symptoms. Inhibiting the abnormal aggregation of Aβ and the hyperphosphorylation of tau proteins is considered the primary and a promising therapeutic approach to treat AD.

F-SLOH as theragnostic agent for AD

In the search for novel therapeutic and diagnostic methods for AD, a research team comprising Professor Li Min, Professor of the Teaching and Research Division and Associate Dean of the School of Chinese Medicine; Professor Ricky Wong Man-shing, Professor of the Department of Chemistry of the Faculty of Science; and Dr Iyaswamy Ashok, Research Assistant Professor of the Teaching and Research Division of the School of Chinese Medicine at HKBU, demonstrated the in vivo therapeutic efficacy of a compound called F-SLOH in reducing the abnormal aggregation of Aβ, the hyperphosphorylation of tau proteins and neuroinflammation in the nerves cells in the brain, thereby improving the learning and memory functions of mice with AD.

F-SLOH is a multi-functional cyanine probe synthesised by a team led by Professor Ricky Wong Man-shing for the detection of biological materials such as proteins and peptides. Its features include real-time visualisation of Aβ aggregation in brains, excellent permeability across the blood-brain barrier and low bio-toxicity. Previous studies showed that F-SLOH could inhibit the abnormal aggregation of Aβ species and provide neuroprotection against neurotoxicity induced by the abnormal aggregation of Aβ in vitro at the cellular level.

F-SLOH improves pathological features in AD mice

To determine the therapeutic efficacy of F-SLOH for AD, the researchers injected or fed F-SLOH to a group of transgenic AD mice. Histopathology and biochemical analyses showed that in mice treated with F-SLOH, Aβ oligomers (one of the Aβ species) and Aβ plaque deposits (the clumps of Aβ) were dramatically reduced in their hippocampus and their brains when compared with the AD mice in the control group who had not been fed F-SLOH.

The researchers also found that F-SLOH can reduce the levels of an amyloid precursor protein that generates Aβ and tau protein hyperphosphorylation. In an immunoblot analysis of the transgenic AD mice brian, the F-SLOH treatment group showed a significant reduction in the levels of the amyloid precursor protein and its metabolites compared to the control group.

In other experiments on the transgenic AD mice after F-SLOH treatment, the researchers separated the soluble and insoluble tau proteins in their brain tissue samples. The results showed that F-SLOH treatment significantly reduced the levels of insoluble tau protein in the brains of AD mice, which forms neurofibrillary tangles, one of the pathological features of AD.

F-SLOH improves memory and cognitive functions in AD mice

Aggregation of Aβ is closely related to the dysfunction of the links between nerve cells and memory decline. The researchers conducted two experiments to test the memory functions of AD mice. In the first experiment, mice were trained to swim in a water maze, reach a platform and remember its position. After the platform was removed, researchers observed whether the mice were able to recall and approach the original position of the platform. Compared to the control group, transgenic AD mice treated with F-SLOH spent more time swimming around the platform's original position, showing that they can better memorise the platform's location.

In the second experiment, mice were placed in a chamber and exposed to an audio tone followed by an instant small electric shock to their feet from the floor of the chamber. On the following day, they were put back in the chamber but without any electric shock. When the mice were exposed to the same audio tone, they "froze" their body movements due to the fear of an electric shock. The transgenic AD mice treated with F-SLOH exhibited a longer freezing time than that of the control group.

The results of the two experiments showed that AD mice treated with F-SLOH have better memories compared to the control group, suggesting that F-SLOH improved AD mice's memory and cognitive functions.

F-SLOH shows early potential for treating AD

The researchers also revealed that F-SLOH degraded the abnormal aggregation of Aβ and reduced the levels of tau protein hyperphosphorylation, the amyloid precursor protein and its metabolites through the activation of the transcription factor EB. Transcription factor EB is the main regulator of the autophagy-lysosomal pathway, a major mechanism for degrading ageing intracellular macromolecular proteins, including the intracellular metabolites such as Aβ aggregates.

Professor Li Min said: "AD patients lose their self-management abilities and require long-term care as the disease progresses. As the population is ageing in Hong Kong, the prevalence of AD is likely to increase. There is an urgent need to develop new drugs that can treat or slow down the progression of AD. The current study suggests that the compound F-SLOH has promising theragnostic potential for treating AD at an early stage."

Professor Ricky Wong Man-shing said: "The study provides the first in vivo evidence that F-SLOH is an effective agent that can target and treat multiple neurodegenerative changes in an AD mouse model. The research findings can drive advancements in AD diagnosis and treatment in humans."


Hashtag: #HongKongBaptistUniversity #HKBU

News from Asia

Wildberries tests ready-to-eat food delivery from restaurants

MOSCOW, RUSSIA - Media OutReach Newswire - 16 July 2025 - Wildberries, a leading digital platform in Eurasia, is launching a pilot service for express delivery of ready-made meals from restaurants...

MSIG Hong Kong’s 2024 Claims Report announces multi-year growth in its claims settlement ratio and highlights award-winning claims processing innovation

94.5% claims settlement ratio was achieved amidst a difficult business environment First year that two categories – Employees' Compensation Hong Kong and Marine - saw settlement ratios of 100% D...

Johnson Electric reports Business and Unaudited Financial Information for the First Quarter of Financial Year 25/26 and Formation of Joint Ventures in the PRC for Humanoid Robotics Business

HONG KONG SAR - Media OutReach Newswire – 16 July 2025 - This news release is made by Johnson Electric Holdings Limited ("Johnson Electric" or the "Company" and together with its subsidiaries, the...

Biotech Breakthroughs in Anti-Aging: Decoding the Hallmarks of Aging and the Longevity Code

The Hong Kong Society of Cosmetic Chemists (HKSCC) Invites Swiss Biotech Expert to unveil scientific truths behind aging Clinical Evidence Confirms Anti-Aging Efficacy of Plant-Based Stem ...

This Summer, Take a Break with a Brick. Join LEGO® Group and Minifigure "Lok Jai" on a Joyful Journey Across 8 "Fun Spots" Explore Hong Kong’s Map of Happiness and Make the Most of Your Holiday

HONG KONG SAR - Media OutReach Newswire - 16 July 2025 - This summer, LEGO® Group teams up with popular minifigure Lok Jai to invite everyone in Hong Kong—young and old—to "Take a Brick" and enjoy...

SY Holdings Issues Positive Profit Alert for 1H 2025: Net Profit Expected to increase by approximately 20%, Platform-Based Tech Revenue Share Surpasses 50%

SHENZHEN, CHINA - EQS Newswire - 16 July 2025 - SY Holdings Group Limited ("SY Holdings" or the "Group", Stock Code: 6069.HK), a leading digital-intelligence technology company focused on "AI + Ind...

SUNRATE Awarded In CNBC’s World’s Top Fintech Companies 2025 List

SINGAPORE - Media OutReach Newswire - 17 July 2025 - SUNRATE, the global payment and treasury management platform, announced today that it has been included in the prestigious CNBC's list of the W...

Reshaping Global Lubricant Supply Chains: Trump-Era Tariffs Driving Industry Pivot Toward Asia

SINGAPORE - Media OutReach Newswire - 17 July 2025 - With the global lubricants industry still adjusting to the lasting impact of U.S. trade policy enacted during the first presidential term ...

Southco Adds New Options To Its E5 Line Of Cam Latches

HONG KONG SAR - Media OutReach Newswire - 17 July 2025 - Southco is adding two new options to its E5 line of quarter-turn cam latches, opening up a variety of new functionalities...

EPIC 2025 Outdid Itself with Record-High 1,200 Applications

Doubled from last year with 87% entering the Hong Kong startup competition from overseas HONG KONG SAR - Media OutReach Newswire - 17 July 2025 - EPIC 2025, organised by Hong Kong Science and Tech...

Australian Businesses Still Stuck in the AI Hype Cycle

Data Governance Failures, ROI Gaps and Unclear Strategy Slowing Progress Despite artificial intelligence (AI) dominating headlines and boardroom ag...

How to ensure your manufacturing business survives international tariff turmoil

Optimising your operations in FY2026 will help you combat the challenges of a volatile trading environment. Up, down, in out…Since the commence...

Why Apptio is Enhancing Visibility into AI and Hybrid Cloud

AI investments have become a strategic priority for business with the mindset that if you're not using AI, you're falling behind. But according to...

Beyond borders: Building a scalable strategy for international hiring

For many Australian businesses, growth increasingly depends on thinking beyond local borders.  As wage pressures rise, and specialised talent pool...

The Next Generation of Maritime Sustainable Solutions

As organizations globally seek innovative ways to improve sustainability and their impact on Earth, the American Waterways Operators (AWO), a lead...

Demand for Home Batteries surges as Federal Rebate Kicks In

A leading provider of energy solutions VoltX Energy has seen a 400% increase in demand for home batteries in the past three weeks as people put d...

Sell by LayBy